Challenging thrombotic scenarios in the myeloproliferative neoplasms: splanchnic vein thrombosis and others

Mar 15, 2017 by in HEMATOLOGY Comments Off on Challenging thrombotic scenarios in the myeloproliferative neoplasms: splanchnic vein thrombosis and others

Figure 19.1 Challenging thrombosis scenarios. MPN, myeloproliferative neoplasm; APC, activated protein C resistance. As reviewed in: Falanga A, Marchetti M. Thrombosis in myeloproliferative neoplasms. Semin Thromb Hemost. 2014;40(3):348–58. Adapted from:…

read more

Managing acute vascular events in patients with myeloproliferative neoplasms

Mar 15, 2017 by in HEMATOLOGY Comments Off on Managing acute vascular events in patients with myeloproliferative neoplasms

html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> 18 Managing acute vascular events in patients with myeloproliferative neoplasms David A. Garcia and Bethany T. Samuelson Case 1 A 62-year-old man is referred to hematology…

read more

The newly diagnosed patient with essential thrombocythemia

Mar 15, 2017 by in HEMATOLOGY Comments Off on The newly diagnosed patient with essential thrombocythemia

Figure 7.1 Flow chart of recommendations for the management of patients with essential thrombocythemia (ET). CV, cardiovascular; HU, hydroxyurea; WHO, World Health Organization. Intervention on lifestyle Thrombosis is a multifactorial…

read more
Get Clinical Tree app for offline access